BioSpace News Archive

American Gene Technologies (AGT), a clinical-stage biotechnology company, announced treatment of the first participant in its Phase I clinical trial to evaluate safety of the cell and gene therapy product AGT103-T. Designated as the RePAIR trial (Restore Potent Antiviral Immune Responses, NCT04561258)

CarepathRx, a leader in pharmacy and medication management solutions, announced a new home infusion pharmacy partnership with Allied Health Solutions, part of the West Virginia University Medicine health system.

SANUWAVE Health, Inc., a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for focused, shockwave systems in the non-medical field presented results from a clinical case series that demonstrated improved wound healing when treated with its FDA-cleared, non-invasive pulsed acoustic cellular expression system dermaPACE® System.

People living with type 2 diabetes in the US may not be being prescribed enough blood glucose monitoring (BGM) test strips to help them optimally manage their diabetes, according to new research from Ascensia Diabetes Care, a leading diabetes care company and makers of CONTOUR® NEXT BGM and test strips

Aptevo Therapeutics Inc., a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIRTM and ADAPTIR-FLEXTM platform technologies announced that the company has initiated the expansion phase of lead anti-leukemia drug candidate, APVO436, in adult patients with acute myeloid leukemia with a multi-center, multi-arm trial using the active recommended dose identified in the dose escalation phase of the study.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial of Brilacidin for COVID-19 has reached 90 percent and that the Company anticipates full enrollment to be completed in approximately two weeks.

For the first time in history, women urologists surpassed 10 percent of the urology workforce in 2020. The average annual growth rate from 2014 – 2020 was nearly nine percent per year for women compared to approximately two percent per year for men.

SINOMED, a leading international medical device company, announced results from the HT Supreme™ Healing-Targeted Drug-Eluting Stent, in complex patients compared to the Xience or Promus family of DES.

RefleXion Medical, Inc., a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, today announced the appointment of three external directors to its board of directors, Renee Ryan, Rana Al-Hallaq, Ph.D., and Alice Schroeder

Diamond Therapeutics Inc. (“Diamond”), a leading psychedelic drug development company focused on sub-perceptual therapies for mental health, is pleased to announce that the head of its clinical advisory board, Dr. Edward Sellers, will be presenting at the NIH’s Psilocybin Research Speaker Series on June 4, 2021.